Clinical Trial Update: A Real-World Study of β-Thalassemia Major Treatment With Luspatercept in Taiwan

View source ↗

Summary

This is a real-world, Taiwan-based study evaluating luspatercept for beta-thalassemia major, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta Thalassemia Major

Drugs mentioned

• REBLOZYL (LUSPATERCEPT)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: β-Thalassemia Major | Status: ACTIVE_NOT_RECRUITING